Biotech’s $400B Problem: The Patent, IP, and Competitive Intelligence Playbook Every Pharma Executive Needs
The path from discovery to commercial dominance has never been more expensive, more legally treacherous, or more dependent on intelligence
January 2018
Understanding Pharmaceutical Competitor Analysis
Strategic Pharmaceutical Competitor Analysis: Intellectual Property Moats and Market Entry Dynamics Pharmaceutical firms operate in an environment where patent expiration
Understanding Pharmaceutical Competitor Analysis Read Post »
